Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate
Journal article published in 2017 by
J. Flaherty,
K. Kim,
A. Jackson,
R. Myers,
M. Subramanian,
K. Agarwal 
,
M. Kin Kong,
K. S. Lee,
R. Balabanska,
M. Ma,
C. Pan,
D. Abdurakhmanov,
H. Bae
,
M. Kin Kong,
K. S. Lee,
R. Balabanska,
M. Ma,
C. Pan,
D. Abdurakhmanov,
H. Bae
